Drug Bioavailability News Today

Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The

CN Bio, a leading organ-on-a-chip company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), has announced that the U.S. Food and Drug Administration (FDA) and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ MPS and their applications using the PhysioMimix™ multi-organ System. Building on the success of prior studies, the system will initially be investigated for improving the preclin